Total Payments
$2,626
2024 Payments
$463.28
Companies
19
Transactions
49
Medicare Patients
1,980
Medicare Billing
$116,889
Payment Breakdown by Category
Food & Beverage$2,626 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,626 | 49 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $370.71 | 3 | $0 (2022) |
| Lilly USA, LLC | $348.96 | 5 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $322.65 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $312.99 | 13 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $198.99 | 2 | $0 (2019) |
| ABBVIE INC. | $164.80 | 3 | $0 (2022) |
| PFIZER INC. | $135.13 | 2 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $111.75 | 3 | $0 (2019) |
| Janssen Biotech, Inc. | $106.19 | 3 | $0 (2024) |
| UCB, Inc. | $105.89 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $463.28 | 9 | Regeneron Healthcare Solutions, Inc. ($134.69) |
| 2023 | $523.87 | 16 | E.R. Squibb & Sons, L.L.C. ($249.17) |
| 2022 | $580.80 | 8 | Lilly USA, LLC ($225.70) |
| 2021 | $120.00 | 1 | Janssen Scientific Affairs, LLC ($120.00) |
| 2020 | $15.17 | 1 | Helsinn Therapeutics (U.S.), Inc. ($15.17) |
| 2019 | $390.54 | 5 | Ortho Dermatologics, a division of Bausch Health US, LLC ($198.99) |
| 2018 | $131.48 | 4 | Biofrontera Inc. ($80.40) |
| 2017 | $401.35 | 5 | Janssen Scientific Affairs, LLC ($120.00) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $94.55 | General |
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.72 | General |
| Category: Immunology | ||||||
| 10/24/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: Immunology | ||||||
| 10/20/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $134.69 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.55 | General |
| Category: Immunology | ||||||
| 04/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $78.02 | General |
| Category: Immunology | ||||||
| 03/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.91 | General |
| Category: Immunology | ||||||
| 03/06/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.38 | General |
| 02/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $60.59 | General |
| Category: Immunology | ||||||
| 10/24/2023 | Blueprint Medicines Corporation | — | Food and Beverage | In-kind items and services | $28.74 | General |
| 09/12/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $40.26 | General |
| Category: Immunology | ||||||
| 08/17/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.49 | General |
| Category: Immunology | ||||||
| 06/01/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $28.62 | General |
| Category: Immunology | ||||||
| 06/01/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.38 | General |
| Category: Immunology | ||||||
| 05/18/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $91.78 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/28/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.29 | General |
| Category: Immunology | ||||||
| 04/04/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Immunology | ||||||
| 03/28/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $14.33 | General |
| Category: Dermatology | ||||||
| 03/16/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.01 | General |
| Category: Immunology | ||||||
| 03/09/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $82.55 | General |
| Category: Dermatology | ||||||
| 02/08/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Immunology | ||||||
| 01/26/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.70 | General |
| Category: Immunology | ||||||
| 01/26/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.42 | General |
| Category: Immunology | ||||||
| 01/18/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $87.00 | General |
| Category: Immunology | ||||||
| 01/10/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 385 | 733 | $84,411 | $24,880 |
| 2022 | 10 | 510 | 939 | $107,090 | $30,870 |
| 2021 | 6 | 461 | 790 | $77,529 | $25,058 |
| 2020 | 10 | 624 | 1,169 | $116,109 | $36,082 |
Total Patients
1,980
Total Services
3,631
Medicare Billing
$116,889
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 158 | $26,136 | $9,908 | 37.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 88 | 117 | $23,474 | $4,557 | 19.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 49 | 58 | $12,821 | $3,958 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 21 | $6,786 | $2,001 | 29.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 68 | 312 | $5,781 | $1,498 | 25.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 16 | 33 | $3,876 | $1,201 | 31.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 12 | $3,338 | $1,023 | 30.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 22 | $2,199 | $733.38 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 149 | 189 | $31,264 | $11,153 | 35.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 60 | 73 | $16,137 | $5,155 | 31.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 105 | 134 | $26,884 | $4,865 | 18.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 29 | 58 | $6,812 | $2,260 | 33.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 75 | 383 | $7,097 | $1,760 | 24.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 41 | 48 | $4,798 | $1,654 | 34.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 13 | 13 | $3,616 | $1,133 | 31.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $3,559 | $1,113 | 31.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 12 | $3,877 | $1,065 | 27.5% |
| 69100 | Biopsy of ear | Office | 2022 | 11 | 14 | $3,044 | $711.11 | 23.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 106 | 116 | $19,042 | $7,728 | 40.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 59 | 71 | $15,577 | $5,239 | 33.6% |
| 17000 | Destruction of skin growth | Office | 2021 | 110 | 119 | $21,905 | $4,626 | 21.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 76 | 92 | $9,102 | $3,637 | 40.0% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 28 | 52 | $6,050 | $2,136 | 35.3% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 82 | 340 | $5,853 | $1,692 | 28.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 141 | 188 | $28,909 | $8,923 | 30.9% |
About Dr. Gregory Richterich, MD
Dr. Gregory Richterich, MD is a Dermatology healthcare provider based in Eugene, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316911274.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Richterich, MD has received a total of $2,626 in payments from pharmaceutical and medical device companies, with $463.28 received in 2024. These payments were reported across 49 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,626).
As a Medicare-enrolled provider, Richterich has provided services to 1,980 Medicare beneficiaries, totaling 3,631 services with total Medicare billing of $116,889. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Eugene, OR
- Active Since 02/15/2006
- Last Updated 06/12/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1316911274
Products in Payments
- TREMFYA (Drug) $331.26
- Sotyktu (Drug) $312.99
- LIBTAYO (Biological) $230.87
- SILIQ (Drug) $198.99
- TALTZ (Drug) $134.85
- Bimzelx (Biological) $105.89
- Skyrizi (Biological) $100.80
- OPZELURA (Drug) $96.88
- Erivedge (Biological) $95.67
- DUPIXENT (Biological) $91.78
- ILUMYA (Biological) $90.75
- EUCRISA (Drug) $87.57
- ATOPIC DERMATITIS - DISEASE (Drug) $85.83
- Ameluz (Drug) $80.40
- RINVOQ (Biological) $48.05
- CIBINQO (Drug) $47.56
- REMICADE (Biological) $25.64
- ILUMYA (tildrakizumab-asmn) injection (Biological) $21.00
- COSENTYX (Drug) $17.08
- Humira (Biological) $15.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Eugene
Dr. Diane Baird, M.d, M.D
Dermatology — Payments: $5,811
Dermatology $5,811
Benjamin Vazquez, Md, MD
Dermatology — Payments: $4,974
Dermatology $4,974
Troy Richey, Md Pc, MD PC
Dermatology — Payments: $3,246
Dermatology $3,246
Dr. Hannibal Eccles, Md, MD
Dermatology — Payments: $1,904
Dermatology $1,904
Cynthia Dreyer, M.d, M.D
Dermatology — Payments: $1,081
Dermatology $1,081
Dr. Chong Wee Foo, M.d, M.D
Dermatology — Payments: $793.74
Dermatology $793.74